Blood / Urine / Tissue collection
Objectives
The collection of blood / urine / tissue following compound administration can allow the identification of a mechanism of action performing biochemical and/or histological analysis. Collected samples can also be sent to Pelvipharm’s client if needed.
Summarized methodology
- Plasma / blood collection: blood samples (venous / arterial) are collected either in conscious or anesthetized animals, immediately placed at 4°C and centrifuged to collect plasma samples.
- Urine collection: Urine harvesting can be performed using metabolic cages and refrigerated collection rack (see metabolic cages), or by direct vesical collection.
Care is particularly taken to appropriately store the blood/plasma and urine samples (liquid nitrogen, -80°C, -20°C, 4°C) and to add appropriate preservatives according the future use of these samples.
- Tissue collections:
Various tissues can be harvested in freshly euthanized animals :
- central nervous system: brain, spinal cord
- cardiovascular / pulmonary system: heart, vessels, lungs
- urinary system: kidney, bladder, urethra, prostate
- sexual system: corpora cavernosa, seminal vesicle, vagina, clitoris, ...
- other systems: striated muscle, digestive tract, liver, …
Tissues can be prepared for in vitro, biochemical or histological purposes as follows :
- dissected at 4°C and mounted in organ bath chambers for reactivity studies (see in vitro organ baths functional experiments with animal tissues)
- snap frozen in liquid nitrogen for future homogeneization and biochemical determinations (see spectrophotometric assays and protein expression)
- embedded in paraffin or cryopreserving milieu (with or without preliminary fixation) for future histological studies (see histology and immunohistology)
Endpoints
- Organ weighing and volume evaluation
- Sample collection
NB: Pelvipharm will gladly study the feasibility of additional administration routes and modalities to meet its client’s needs.

Links to applicable Targeted disorders / Pathophysiological models
- Atherosclerosis
- BPH (Benign Prostatic Hyperplasia)
- Diabetes
- ED (Erectile Dysfunction)
- Ejaculatory disorders (premature or delayed ejaculation / anejaculation)
- FSD (Female Sexual Dysfunction)
- Hypertension
- IC (Interstitial Cystitis) / Painful bladder syndrome
- Metabolic Syndrome and Obesity
- Myocardial Infarction
- NDO (Neurogenic Detrusor Overactivity)
- OAB (Overactive Bladder)
- SCI (Spinal Cord Injury)